Genie's Therapeutics
Genie Therapeutics, founded in 2007, uses patented gene therapy technologies for skin restoration and rejuvenation.
Founded
2018Genie Therapeutics, founded in 2007, uses patented gene therapy technologies for skin restoration and rejuvenation.
Genie Therapeutics, founded in 2007 by Dr. Tabor, focuses on developing advanced gene therapy technologies aimed at skin restoration and rejuvenation. The company's core mission is to utilize patented, third-generation non-viral gene transfer methods to heal, restore, and regenerate skin, thereby improving the quality of life for countless patients. Genie's Therapeutics offers innovative therapeutic solutions designed to rejuvenate and transform skin, with a primary market focus on individuals seeking advanced dermatological treatments.
Notable affiliated individuals include Dr. Tabor, whose expertise and vision drive the company's pioneering efforts in gene therapy. Genie Therapeutics has achieved significant milestones in the field of dermatological gene therapy, securing patents for its unique non-viral delivery systems. The company's impact is evident in its ability to provide cutting-edge treatments that address various skin conditions, positioning it as a leader in the biotechnology sector focused on skin health and regeneration.
Companies similar to Genie's Therapeutics include Intergalactic Therapeutics, Histogen, Dermaliq Therapeutics and Aldena Therapeutics.
Genie's Therapeutics was founded in 2018.
Genie's Therapeutics' headquarters is located in Ojai, CA, US.
Genie's Therapeutics' most recent funding round was for $50k (USD) in July 2023.
As of Jul 27, 2023, Genie's Therapeutics has disclosed funding of $50k (USD). Undisclosed round amounts are excluded.
Genie's Therapeutics has 2 employees as of Feb 5, 2024.
Aldena Therapeutics
